Status:
COMPLETED
Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Localized Osteosarcoma
Metastatic Osteosarcoma
Eligibility:
All Genders
Up to 39 years
Brief Summary
This trial studies biomarker expression in tissue samples from patients with bone sarcomas. Studying biomarker in tissue samples from patients with cancer in the laboratory may help doctors identify a...
Detailed Description
STUDY SUBTYPE: Ancillary/Correlative OBSERVATIONAL STUDY MODEL: Case-only TIME PERSPECTIVE: Retrospective BIOSPECIMEN RETENTION: Samples without DNA BIOSPECIMEN DESCRIPTION: Tissue samples obtaine...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Tissue samples from patients with osteosarcomas obtained from the CHTN:
- P9754 clinical trial for patients with non-metastatic osteosarcoma
- AOST0121 clinical trial for patients with metastatic or recurrent osteosarcoma
Exclusion
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT01807052
Start Date
November 1 2009
End Date
May 1 2016
Last Update
May 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Oncology Group
Monrovia, California, United States, 91006-3776